Exploring the disease burden and quality of life in patients with short bowel syndrome with intestinal failure: Insights from exit interviews in the glepaglutide EASE SBS-1 phase 3 trial.

Mercer DF et al.

NCBI PubMed Central · Papers · License: Open Access

philosophy of mind

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 415238
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.